FMRP appears to regulate glioblastoma stem-like cell proliferation through both canonical WNT/β-catenin and non-canonical WNT-ERK1/2 signaling pathways, influencing the stability of key transcription factors involved in glioma cell malignancy. The gene discussed is FMR1; the disease is glioblastoma.